| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| PYLARIFY | $273.26M | $259.76M | $265.95M | $257.65M | $250.64M | $240.62M | $240.2M | $240.92M |
| Oncology | — | — | — | — | — | — | — | $240.92M |
| Definity | $78.1M | $76.97M | $86.16M | $79.21M | $83.94M | $81.79M | $85.31M | $84.63M |
| Cardiology | — | — | — | — | — | — | — | $84.63M |
| Neuraceq | — | — | — | — | — | $20.44M | $31.01M | $35.44M |
| Neurology | — | — | — | — | — | — | — | $35.44M |
| Strategic Partnerships And Other | $8.73M | $15.25M | $7.7M | $10.75M | $11.59M | $13.71M | $23.34M | $16.34M |
| Licenseand Royalty Revenues | $1.34M | $4.13M | $3M | $5.85M | $3.5M | $7.33M | $17.37M | $7.48M |
| SPECT Business | — | — | — | — | — | — | — | $0 |
| Total | $394.09M | $378.73M | $391.11M | $372.76M | $378.05M | $384.01M | $406.79M | $377.33M |